Skip to menu

We deliver the latest news of
the SD BIOSENSOR

ss
SD Biosensor shares the company news, including product development and global business activities, through the newsroom board.

NEWS

  1. [APLMA] Malaria Gamechangers : A Health Innovation Series

    Dr. Cho will join online roundtable discussion as a panelist in webinar ‘Malaria Gamechangers : A Health Innovation Series’ organized by APLMA(Asia Pacific Leadership of Malaria Alliance) on the 23rd July 2020. During the roundtable panelists will highlight the importance of testing, tracking and treating malaria and other febrile illnesses, as we are close to malaria elimination in Asia Pacific. The session will be streamed online in live and an invitation will be shared as soon as ...
    Date2020.07.10 CategoryNEWS Views36
    Read More
  2. SD BIOSENSOR is invited to join IAG for ACT-A Dx Partnership.

    SD Biosensor is invited to join IAG (Industry advisory group) for ACT-A Dx Partnership (Access to COVID-19 Tool – Accelerator Diagnostic Partnership), and participated to inauguration ceremony held online on the 9th July 2020. The ACT-ACCELERATOR Diagnostics Partnership works to ensure the right COVID diagnostic test is available to all who need it by spurring innovation in new diagnostic tests and digital solutions, creating effective and efficient markets, ensuring supply and expanding c...
    Date2020.07.10 CategoryNEWS Views7
    Read More
  3. Brazil Drive-Through starts to use RDT for detecting COVID-19.

    photo & video by local distributor of SD BIOSENSOR STANDARD Q COVID-19 Ag test is being used in Brazil Drive-through to detect COVID-19. Related video is below, Brazil Drive-through.mp4 ​ For product's specification, http://www.sdbiosensor.com/xe/product/7672
    Date2020.07.10 CategoryNEWS Views28
    Read More
  4. STANDARD Q COVID-19 IgM/IgG Duo in Mozambique.

    STANDARD Q COVID-19 IgM/IgG Duo was broadcasted in one of the broadcasting company in Mozambique. For product's specification, http://www.sdbiosensor.com/xe/product/7662 You can see the related video through below URL: https://youtu.be/_b5--SBlE3Q
    Date2020.07.03 CategoryNEWS Views194
    Read More
  5. SD BIOSENSOR will annually donate the 250 million won to RIGHT Fund.

    SD BIOSENSOR will annually donate the 250 million won to Research Investment for Global Health Technology Fund(RIGHT Fund) for supporting the infectious disease research.
    Date2020.07.03 CategoryNEWS Views33
    Read More
  6. ICMR approved the use of antigen test of SD BIOSENSOR.

    ICMR (Indian Council of Medical Research) approved the use of Antigen test of SD BIOSENSOR in terms of early detection of COVID-19 with high specificity. The product ICMR approved is, STANDARD Q COVID-19 Ag test, a rapid chromatographic immunoassay for qualitative detection of specific antigens to SARS-CoV-2. The thing we need to note is, SD BIOSENSOR’s STANDARD Q COVID-19 Ag test becomes the first of its kind to get ICMR validation. It proves not only the high product quality of SD BIOSEN...
    Date2020.06.19 CategoryNEWS Views934
    Read More
  7. STANDARD Q HIV 1/2 Ab 3-Line Test has been approved by WHO PQ.

    [STANDARD Q HIV 1/2 Ab 3-Line Test has been approved by WHO PQ.] STANDARD Q HIV 1/2 Ab 3-Line Test has been approved by WHO PQ in June 10th, 2020. Please find more detail information through the official website of WHO. https://www.who.int/diagnostics_laboratory/evaluations/pq-list/hiv-rdts/200612_final_pqpr_pqdx_0383_117_00_standard_hiv_line_test.pdf And also you can find specification of STANDARD Q HIV 1/2 Ab 3-Line Test through the official website of SD BIOSENSOR. http://sdbiosensor.com/xe/p...
    Date2020.06.17 CategoryNEWS Views136
    Read More
  8. FDA issues an EUA for STANDARD M nCoV Real-Time Detection Kit.

    US FDA gives EUA (Emergency Use Authorization) to STANDARD M nCoV Real-Time Detection Kit made by SD BIOSENSOR in 23 April, 2020. STANDARD M nCoV Real-Time Detection Kit, which is approved by US FDA EUA, is used for rapid identification and detection of novel coronavirus (2019-nCoV) nucleic acids in human nasopharyngeal swabs and throat swab samples. This is RT-PCR test that amplifies and diagnoses a specific gene sequence of COVID-19. With this approval, SD BIOSENSOR has the authority to supply...
    Date2020.04.24 CategoryNEWS Views11243
    Read More
  9. US FEMA to receive 300,000 coronavirus tests from SD BIOSENSOR.

    CNN, one of global broadcasting systems in United States, reported that FEMA (Federal Emergency Management Agency) awarded a contract to SD BIOSENSOR last week to provide coronavirus test kits. Please find attached articles. (EN) https://edition.cnn.com/2020/04/13/politics/south-korea-coronavirus-tests/index.html (KR) https://n.news.naver.com/article/081/0003082485?lfrom=kakao
    Date2020.04.14 CategoryNEWS Views1960
    Read More
  10. [British Headline] COVID-19 Antibody Test is a Potential Game Changer!

    Public attention for Covid-19 antibody kit developed by SD BIOSENSOR is increasing rapidly. Under this circumstances, the U.K government Cheif Scientific Advisor, Patrick Vallance, has descirbed COVID-19 antibody test as a potential "game changer", and it would be "transformational" said Chris Whitty, the Chief Medical Advisor. The following articles will help you understand why the British government is so serious about using COVID-19 antibody tests to control this pandemic disaster. https://ww...
    Date2020.03.20 CategoryNEWS Views2997
    Read More
  11. Supporting the World Fight Against COVID-19

    SD BIOSENSOR has developed four different diagnostic kits for the detection of novel coronavirus(COVID-19). STANDARD M nCOV Real-Time Detection kit has been approved by South Korea EUA since Feburary 2020, and is already playing an important role as a confirmation method for COVID-19 in Korean domestic market. Due to the fact that WHO currently declared COVID-19 outbreak a pandemic, the needs for rapid screening kits are newly emerging. In keeping with this trend, we expects our STANDARD Q and S...
    Date2020.03.19 CategoryNEWS Views4028
    Read More
  12. Introducing SD BIOSENSOR’s WHO Prequalified RDT Line-up

    STANDARD Q HCV Ab Test, STANDARD Q Malaria P.f Ag Test, STANDARD Q Malaria P.f/P.v Ag Test, and STANDARD Q Malaria P.f/Pan Ag Test have been listed on the World Health Organization’s prequalification project. Please find the public reports and performance data through the official website of the World Health Organization. https://www.who.int/diagnostics_laboratory/evaluations/PQ_list/en/ If you have any further inquiry, please feel free to contact our sales representatives or via email(sal...
    Date2020.03.19 CategoryNEWS Views3027
    Read More
  13. Expert Review Panel for Diagnostics approval expands access to a G6PD deficiency test that supports P. vivax malaria treatment and elimination initiatives

    The STANDARD™ G6PD has achieved provisional Expert Review Panel for Diagnostics (ERPD) approval, which enables procurement with Global Fund and Unitaid funds. Point-of-care diagnostics for G6PD deficiency play a critical role in supporting appropriate treatment of Plasmodium vivax malaria and efforts to eliminate the disease. Up to 2.85 billion people may be at risk of infection with Plasmodium vivax malaria. It is the most difficult type of malaria to fully treat because a form of the mal...
    Date2019.10.08 CategoryNEWS Views1531
    Read More
  14. CE-IVD Certification of STANDARD™ Q HCV Ab

    SD BIOSENSOR receives CE-IVD mark for STANDARD™ Q HCV Ab Test. It is SD BIOSENSOR’s 1st 'List A' test, in compliance with the in vitro Diagnostic Directive (IVDD) 98/79/EC. STANDARD™ Q HCV Ab Test qualitatively analyzes antibodies specific to hepatitis C virus in serum and plasma using immunochromatography. With a simple test method, the screening test result can be obtained within 5 minutes with outstanding sensitivity and specificity. Diagnostic Sensitivity : 100.0% (4...
    Date2019.09.11 CategoryNEWS Views574
    Read More
  15. Global Fund ‘ERPD’ Authorization: STANDARD™ Q HIV/Syphilis Combo, Q Syphilis Ab

    The Global Fund concluded that our STANDARD™ Q HIV/Syphilis Combo and Q Syphilis Ab are eligible for procurement with Global Fund and/or UNITAID resources until 25 August 2020. We are working on WHO PQ approval of STANDARD™ Q HIV/Syphilis Combo Test. The expected approval is around Q1 2020 which means the procurement will be continued beyond August 2020. The product was evaluated successfully in Belgium, Germany, Congo, Peru, and more evaluations are ongoing in Ghana and India. [Publi...
    Date2019.08.30 CategoryNEWS Views953
    Read More
  16. STANDARD™ G6PD Test’s Official Research Report Is Published!

    Tafenoquine (TQ; Krintafel) is FDA approved medicine that compensates Primaquine (PQ) in its long term dose (14 days ~ 8 weeks). TQ can cure P. v malaria infection at liver-stage, and prevent relapse. However, because of its potential risks of hemolysis to G6PD deficient people, WHO have recommended that all people should test G6PD or need to know their G6PD activity status before administering to this treatment. G6PD deficiency is associated with X-chromosome, so for male, their G6PD activity is...
    Date2019.01.14 CategoryNEWS Views7647
    Read More
  17. STANDARD™ GlucoNavii GDH now available for newborn testing.

    The new specification of STANDARD™ GlucoNavii GDH has made it available to test neonate only for professional use. STANDARD™ GlucoNavii GDH has been tested with neonatal samples at Gauhati Medical College & hospital in India from 14th of March to 27th of June, 2018. The total number of newborn samples was 52, and the age of subjects was between 2 hours to 5 days with HCT range of 31%~66%. Each sample was tested twice with 3 different lots of strips which lead to more than 300 tes...
    Date2019.01.09 CategoryNEWS Views4776
    Read More
Board Pagination Prev 1 Next
/ 1